Premature Delivery

2

Review clinical trials related to Premature Delivery. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth

Preterm birth is a major cause of mortality and long-term disability. Bacterial vaginosis (BV) is a frequent form of dysbiosis that is often asymptomatic and increases the risk of preterm birth. BV is usually diagnosed using conventional tools such as the Nugent score. Molecular diagnosis of BV has now been shown to be more reproducible and to provide a more accurate characterization of dysbiosis. The main objective of this study is to evaluate the effectiveness of a self screen and treat strategy for vaginal flora dysbiosis, based on molecular point of care (POC) multiplex technology before 18 weeks' gestation, in reducing the rate of preterm birth among pregnant women at high risk, compared with usual care. The hypothesis is that a Screen-and-Treat strategy using molecular biology among women with previous preterm or/and an history of late abortion could be effective in reducing preterm births by 40%.

Participants needed: 1,794
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: Assistance Publique Hopitaux De MarseilleUpdated: Aug 3, 2026
Eligibility criteria

Pregnant woman over 18 years of age; [+6]

- Woman of legal age under legal protection; [+12]

Status: Not yet recruiting

Effect of Intelligent Intervention Strategies on Self-efficacy and Hospital Readiness of Parents of Preterm Infants

1. Construct intelligent management intervention plan for parents of preterm infants from hospital to family based on the medical and health system suitable for China's national conditions. 2. Clinical randomized controlled trials were conducted to verify and evaluate the feasibility and application effect of the intervention program.

Participants needed: 84
Trial details
Age: 18-100Biological sex: AllType: InterventionalSponsor: Shantou University Medical CollegeUpdated: Oct 10, 2024
Eligibility criteria

Inclusion criteria for premature infants ① gestational age < 37 weeks;② Prema... [+1]

Exclusion criteria for preterm infants ① intrauterine developmental retardation... [+1]